Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets [Phase 1, Phase 2]
A Phase 1/2 trial evaluating tolerance, pharmacokinetics and efficacy of TQ-A3334 tablets for non-small cell lung cancer has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer [Phase 1]
Phase 1 trial evaluating the addition of pembrolizumab to standard antiretroviral therapy in HIV-positive patients with cancer. The study ha…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results [Phase 1]
This Phase 1 trial update reports safety data and early results for GH21 capsules in patients with advanced solid tumors, including non-smal…
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors
This clinical trial update reports on progression-free survival and participant experience for metastatic ALK-positive non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy
Completed real-world study of locally advanced or metastatic non-small cell lung cancer patients who progressed after first-line EGFR-TKI th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
Clinical trial update noting the completion of a study evaluating dynamic perfusion computed tomography in patients with localized non-small…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating RO5126766 in patients with advanced KRAS-mutant non-small ce…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations [Phase 1]
Phase 1 clinical trial evaluating BPI-1178 in combination with Osimertinib for advanced non-small cell lung cancer with EGFR mutations; curr…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
Clinical trial investigating the identification and characterization of sleep disorders in a population of patients with non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC [Phase 3]
Phase III study comparing toripalimab plus chemotherapy to placebo plus chemotherapy in resectable stage II-III non-small cell lung cancer. …
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery [Phase 1]
A Phase 1 study evaluating the combination of docetaxel, cisplatin, and erlotinib in patients with Stage I-III non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of dasatinib and osimertinib in advanced EGFR-mutant non-small cell lung cancer has been termin…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of AMG 160 in non-small cell lung cancer was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants [Phase 1]
Phase 1 study to learn how BAY2927088 affects blood levels of dabigatran and rosuvastatin when taken together in healthy participants; spons…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants [Phase 1]
Phase 1 study evaluating the drug interaction between BAY2927088 and Midazolam, assessing whether BAY2927088 alters Midazolam exposure when …
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II [Phase 2]
Phase II ORIGIN trial (SAKK 17/18) evaluating first-line gemcitabine with atezolizumab in malignant pleural mesothelioma and non-small cell …
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PRT3645 conducted by Prelude Therapeutics in patients with several advanced solid tumors has completed, including breast …
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating the combination of radiosurgery and nivolumab for brain metastases in various cancers, with complet…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone [Phase 1, Phase 2]
A Phase 1/2 study comparing gefitinib with olaparib versus gefitinib alone in non-small cell lung cancer has completed, and results have bee…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations [Phase 2]
Phase 2 clinical trial update for a targeted therapy in incurable non-small cell lung cancer with EGFR mutations; the study was terminated a…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) [Phase 2]
Phase 2 trial evaluating osimertinib with Locally Ablative Radiotherapy in patients with synchronous oligo-metastatic EGFR-mutant non-small …
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: TGRX-326 Pharmacokinetic Drug Interaction [Phase 1]
Phase 1 pharmacokinetic drug interaction study of TGRX-326 in Non-Small Cell Lung Cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Cios Mobile 3D Spin for Robotic Bronchoscopy
Clinical trial update indicates the Mayo Clinic-sponsored study evaluating the Cios Mobile 3D Spin for robotic bronchoscopy has completed. T…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: PPIO-006 Primary Tumor Resection for IVa NSCLC
A clinical trial update confirms the completion of NCT06232967, evaluating primary tumor resection for stage IVa non-small cell lung cancer,…